Targazyme
Reid Bissonnette is an experienced professional in the field of Immuno-Oncology, Oncology, and Immunology. Currently serving as a Consultant at Xenetic Biosciences, Inc. and Radionetics Oncology, as well as holding advisory roles at Circulants and Demigos. Previously, Reid held the position of Vice President of Immuno-Oncology at TargaZyme, Inc. with a background in Pharmacology and Oncology Drug Discovery and Development. With a PhD in Tumor Immunology and Cellular Immunology from McGill University, Reid's expertise is highly valuable in the pharmaceutical industry.